Literature DB >> 27131431

Reverse immunoediting: When immunity is edited by antigen.

Anna Merlo1, Silvia Dalla Santa2, Riccardo Dolcetti3, Paola Zanovello4, Antonio Rosato5.   

Abstract

Immune selective pressure occurring during cancer immunoediting shapes tumor features revealed at clinical presentation. However, in the "Escape" phase, the tumor itself has the chance to influence the immunological response. Therefore, the capacity of the immune response to sculpt the tumor characteristics is only one side of the coin and even the opposite is likely true, i.e. that an antigen can shape the immune response in a sort of "reverse immunoediting". This reciprocal modeling probably occurs continuously, whenever the immune system encounters a tumor/foreign antigen, and can be operative in the pathogen/immune system interplay, thus possibly permeating the protective immunity as a whole. In line with this view, the characterization of a T cell response as well as the design of both active and passive immunotherapy strategies should also take into account all Ag features (type, load and presentation). Overall, we suggest that the "reverse immunoediting" hypothesis could help to dissect the complex interplay between antigens and the immune repertoire, and to improve the outcome of immunotherapeutic approaches, where T cell responses are manipulated and reprogrammed.
Copyright © 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigen; Cancer; Immunodominance; Immunoediting; Immunotherapy; Virus

Mesh:

Substances:

Year:  2016        PMID: 27131431     DOI: 10.1016/j.imlet.2016.04.015

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Phenylboronic ester-modified polymeric nanoparticles for promoting TRP2 peptide antigen delivery in cancer immunotherapy.

Authors:  Qiyan Wang; Zhipeng Dong; Fangning Lou; Yunxue Yin; Jiahao Zhang; Hanning Wen; Tao Lu; Yue Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis.

Authors:  Guanchao Ye; Yafei Liu; Lan Huang; Chunyang Zhang; Yinliang Sheng; Bin Wu; Chunli Wu; Yu Qi
Journal:  Ann Transl Med       Date:  2021-08

Review 3.  Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.

Authors:  Hassan Sadozai; Thomas Gruber; Robert Emil Hunger; Mirjam Schenk
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

4.  Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.

Authors:  Zixin Guo; Jingyu Huang; Yujin Wang; Xiao-Ping Liu; Wei Li; Jie Yao; Sheng Li; Weidong Hu
Journal:  Front Genet       Date:  2020-06-12       Impact factor: 4.599

5.  NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.

Authors:  Cui Zhao; Jian Liu; Yifei Liu; Jianguo Zhang; Haomiao Zhou; Xin Qian; Hui Sun; Xuewen Chen; Miaosen Zheng; Tingting Bian; Lei Liu
Journal:  Cancer Cell Int       Date:  2021-04-20       Impact factor: 5.722

6.  Comprehensive Analysis to Identify Enhancer-Regulated Inflammation-Associated Genes in Lung Adenocarcinoma.

Authors:  Xi Li; Xinling Li; Lina Ding
Journal:  Cancer Manag Res       Date:  2021-09-11       Impact factor: 3.989

Review 7.  The chemistry and efficacy benefits of polysaccharides from Atractylodes macrocephala Koidz.

Authors:  Congying Liu; Shengguang Wang; Zedong Xiang; Tong Xu; Mengyuan He; Qing Xue; Huaying Song; Peng Gao; Zhufeng Cong
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

8.  Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.

Authors:  Yi Wan; Xin Wang; Ting Liu; Tianyu Fan; Zugui Zhang; Bin Wang; Bei Zhang; Zibin Tian; Tao Mao; Zheng Gong; Li Zhang
Journal:  Cancer Med       Date:  2021-05-04       Impact factor: 4.452

9.  Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action.

Authors:  Charles L Hitchcock; Stephen P Povoski; Cathy M Mojzisik; Edward W Martin
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.